Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Evaluation of Dyspepsia with Optimal and Suboptimal Gastric Emptying Tests in Patients with Euthyroid Goiter

Author(s): Sule Ceylan* and Necati Yilmaz

Volume 19, Issue 14, 2023

Published on: 09 March, 2023

Article ID: e090223213544 Pages: 10

DOI: 10.2174/1573405619666230209123957

Price: $65

conference banner
Abstract

Objective: The presence of gastroparesis in patients with dyspepsia can be evaluated by gastric emptying scintigraphy. We aimed to evaluate gastroparesis with optimal solid gastric emptying scintigraphy and suboptimal liquid gastric emptying scintigraphy in euthyroid goiter patients with dyspepsia.

Methods: We included 67 patients diagnosed with euthyroid goiter with dyspepsia complaints. The patients did not use any medication and did not have any other chronic diseases. Solid and liquid gastric emptying scintigraphy was performed on all patients. In our retrospective study; the images were reevaluated. The region of interest was plotted on the area compatible with the stomach and timeactivity curves were obtained. The correlation of solid and liquid gastric emptying test results was evaluated.

Results: Twelve (18%) of the patients were male and the mean age of the patients was 64 (49-75). There is a correlation between solid and liquid gastric emptying scintigraphy (p< 0.0005, r: 0.0880). Solid gastric emptying time was prolonged in 27 patients (40%). Liquid gastric emptying was prolonged in 23 patients (34%). Solid gastric emptying was also prolonged in all patients with prolonged liquid gastric emptying.

Conclusion: According to the results of the optimal gastric emptying test performed with radio-labeled solid food. The rate of gastroparesis was low in our patient group with dyspepsia complaints. However, there is a correlation between the optimal test and suboptimal gastric emptying test results in our patient group. Liquid gastric emptying scintigraphy may be preferred in specific patient groups in case of suspected gastroparesis because of its easy application and short duration.

Keywords: Gastric emptying scintigraphy, nanocolloid, euthyroid goiter, dyspepsia, gastroparesis, sulfur colloid.

Graphical Abstract

[1]
Führer D, Bockisch A, Schmid KW. Euthyroid goiter with and without nodules diagnosis and treatment. Dtsch Arztebl Int 2012; 109(29-30): 506-15.
[PMID: 23008749]
[2]
Führer D, Schmid KW. Benign thyroid nodule or thyroid cancer? Internist 2010; 51(5): 611-9.
[PMID: 20405098]
[3]
Gharib H, Papini E, Paschke R, et al. American association of clinical endocrinologists, associazione medici endocrinologi, and european thyroid association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: Executive summary of recommendations. J Endocrinol Invest 2010; 33(5): 287-91.
[http://dx.doi.org/10.1007/BF03346587] [PMID: 20479572]
[4]
Paschke R, Reiners C, Führer D, Schmid KW, Dralle H, Brabant G. Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Dtsch Med Wochenschr 2005; 130(31/32): 1831-6.
[http://dx.doi.org/10.1055/s-2005-871906] [PMID: 16052449]
[5]
Karges W, Dralle H, Raue F, et al. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes 2004; 112(1): 52-8.
[http://dx.doi.org/10.1055/s-2004-815727] [PMID: 14758572]
[6]
Dressler J, Grünwald F, Leisner B, et al. Guideline for radioiodine therapy for benign thyroid diseases (version 4). Nucl Med (Stuttg) 2007; 46(5): 220-3.
[http://dx.doi.org/10.1160/nukmed-0287] [PMID: 17938758]
[7]
Hafeez M, Hussain F, Salamat A, Khan MB. Gastric emptying scintigraphy in postprandial distress syndrome. Pak J Med Sci 2018; 34(1): 27-31.
[http://dx.doi.org/10.12669/pjms.341.14137] [PMID: 29643873]
[8]
Farrell MB. Gastric Emptying Scintigraphy. J Nucl Med Technol 2019; 47(2): 111-9.
[http://dx.doi.org/10.2967/jnmt.117.227892] [PMID: 31167827]
[9]
Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy: A joint report of the American neurogastroenterology and motility society and the society of nuclear medicine. J Nucl Med Technol 2008; 36(1): 44-54.
[http://dx.doi.org/10.2967/jnmt.107.048116] [PMID: 18287197]
[10]
Donohoe KJ, Maurer AH, Ziessman HA, et al. Procedure guideline for adult solid-meal gastric-emptying study 3.0. J Nucl Med Technol 2009; 37(3): 196-200.
[http://dx.doi.org/10.2967/jnmt.109.067843]
[11]
Drubach LA, Kourmouzi V, Fahey FH. Cheese is a reliable alternative meal for solid-phase gastric emptying study. Nucl Med Commun 2010; 31(5): 430-3.
[http://dx.doi.org/10.1097/MNM.0b013e328333d2f0] [PMID: 20145582]
[12]
Pelletier-Galarneau M, Sogbein OO, Pham X, et al. Multicenter validation of a shortened gastric-emptying protocol. J Nucl Med 2015; 56(6): 873-6.
[http://dx.doi.org/10.2967/jnumed.115.155366] [PMID: 25883124]
[13]
Knight LC. Update on gastrointestinal radiopharmaceuticals and dosimetry estimates. Semin Nucl Med 2012; 42(2): 138-44.
[http://dx.doi.org/10.1053/j.semnuclmed.2011.11.001] [PMID: 22293168]
[14]
Klingensmith WC III, Rhea KL, Wainwright EA, Hopper OW. The gastric emptying study with oatmeal: Reference range and reproducibility as a function of age and sex. J Nucl Med Technol 2010; 38(4): 186-90.
[http://dx.doi.org/10.2967/jnmt.110.077065] [PMID: 21078783]
[15]
Maurer AH. Gastrointestinal Motility, Part 1: Esophageal Transit and Gastric Emptying. J Nucl Med 2015; 56(8): 1229-38.
[PMID: 26025963]
[16]
Ziessman HA, O’Malley JP, Thrall JH, Fahey FH. Gastrointestinal System. In: The Requisites: Nuclear Medicine. (4th ed.). Philadelphia: Elsevier Sanders 2014; pp. 294-305.
[17]
Maurer AH, Yu D, Lu X, et al. Addition of small‐bowel transit scintigraphy to gastric emptying for assessment of patients with upper gastrointestinal symptoms. Neurogastroenterol Motil 2021; 33(2): e13987.
[http://dx.doi.org/10.1111/nmo.13987] [PMID: 32996253]
[18]
Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res 2004; 13(10): 1737-49.
[http://dx.doi.org/10.1007/s11136-004-9567-x] [PMID: 15651544]
[19]
Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 2004; 127(5): 1592-622.
[http://dx.doi.org/10.1053/j.gastro.2004.09.055] [PMID: 15521026]
[20]
Yu D, Ramsey FV, Norton WF, et al. The burdens, concerns, and quality of life of patients with gastroparesis. Dig Dis Sci 2017; 62(4): 879-93.
[http://dx.doi.org/10.1007/s10620-017-4456-7] [PMID: 28110376]
[21]
Gumus A, Ozcelik N, Yilmaz Kara B, Ozyurt S, Sahin U. Thyroid gland disease as a comorbid condition in COPD. Pulm Med 2021; 2021: 1-6.
[http://dx.doi.org/10.1155/2021/7479992] [PMID: 34745661]
[22]
Bjoro T, Holmen J, Krüger O, et al. Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. Eur J Endocrinol 2000; 143(5): 639-47.
[http://dx.doi.org/10.1530/eje.0.1430639] [PMID: 11078988]
[23]
Ahmad T, Chaudhary SC, Usman K, et al. Prevalence of thyroid dysfunction in chronic obstructive pulmonary disease patients in a tertiary care center in North India. J Family Med Prim Care 2018; 7(3): 584-8.
[http://dx.doi.org/10.4103/jfmpc.jfmpc_84_17] [PMID: 30112314]
[24]
Singh L, Jain A, Agrawal A, Tandon R, Kumar H. A study of prevalence of thyroid disorders in chronic obstructive pulmonary disease patients at a tertiary care center in U.P. Int J Contemp Med Res 2016; 3: 1239-42.
[25]
Verma S, Gautam S, Bhan U, et al. To study the assoc ıat ıon of thyro ıd dysfunct ıon ın chron ıc obstruct ıve pulmonary dısease patıents (a cross sectıonal prevalence study sıngle centre only). J Evol Med Dent Sci 2019; 8(28): 2230-3.
[http://dx.doi.org/10.14260/jemds/2019/488]
[26]
Planck T, Lantz M, Perros P, et al. Use of thyroid hormones in hypothyroid and euthyroid patients: A 2020 thesis questionnaire Survey of members of the Swedish Endocrine Society Front Endocrinol 2021; 12: 795111.
[27]
Taylor PN, Albrecht D, Scholz A, et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018; 14(5): 301-16.
[http://dx.doi.org/10.1038/nrendo.2018.18] [PMID: 29569622]
[28]
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MPJ. 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism. Eur Thyroid J 2012; 1(2): 55-71.
[http://dx.doi.org/10.1159/000339444] [PMID: 24782999]
[29]
Peterson SJ, Cappola AR, Castro MR, et al. An online survey of hypothyroid patients demonstrates prominent dissatisfaction. Thyroid 2018; 28(6): 707-21.
[http://dx.doi.org/10.1089/thy.2017.0681] [PMID: 29620972]
[30]
Socialstyrelsen. 2019. Available from: https://www.socialstyrelsen.se/statistikoch-data/register/alla-register/lakemedelsregistret/
[31]
Taylor PN, Iqbal A, Minassian C, et al. Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: Evidence from a large community-based study. JAMA Intern Med 2014; 174(1): 32-9.
[http://dx.doi.org/10.1001/jamainternmed.2013.11312] [PMID: 24100714]
[32]
Medici BB, Nygaard B, la Cour JL, et al. Changes in prescription routines for treating hypothyroidism between 2001 and 2015: An observational study of 929,684 primary care patients in Copenhagen. Thyroid 2019; 29(7): 910-9.
[http://dx.doi.org/10.1089/thy.2018.0539] [PMID: 31017048]
[33]
Petersen M, Knudsen N, Carlé A, et al. Increased incidence rate of hypothyroidism after iodine fortification in Denmark: A 20-year prospective population-based study. J Clin Endocrinol Metab 2019; 104(5): 1833-40.
[http://dx.doi.org/10.1210/jc.2018-01993] [PMID: 30551165]
[34]
Garber JR, Cobin RH, Gharib H, et al. Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 18(6): 988-1028.
[http://dx.doi.org/10.4158/EP12280.GL] [PMID: 23246686]
[35]
Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: Prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid 2014; 24(12): 1670-751.
[http://dx.doi.org/10.1089/thy.2014.0028] [PMID: 25266247]
[36]
Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in women with thyroid peroxidase antibodies before conception. N Engl J Med 2019; 380(14): 1316-25.
[http://dx.doi.org/10.1056/NEJMoa1812537] [PMID: 30907987]
[37]
Wang X, Zhang Y, Tan H, et al. Effect of levothyroxine on pregnancy outcomes in women with thyroid autoimmunity: A systematic review with meta-analysis of randomized controlled trials. Fertil Steril 2020; 114(6): 1306-14.
[http://dx.doi.org/10.1016/j.fertnstert.2020.06.034] [PMID: 32912635]
[38]
Perros P, Van Der Feltz-Cornelis C, Papini E, Nagy EV, Weetman AP, Hegedüs L. The enigma of persistent symptoms in hypothyroid patients treated with levothyroxine: A narrative review. Clin Endocrinol (Oxf) 2021; 00: cen.14473.
[http://dx.doi.org/10.1111/cen.14473] [PMID: 33783849]
[39]
Escobar-Morreale HF, Botella-Carretero JI, del Rey FE, de Escobar GM. Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005; 90(8): 4946-54.
[http://dx.doi.org/10.1210/jc.2005-0184] [PMID: 15928247]
[40]
Grozinsky-Glasberg S, Fraser A, Nahshoni E, Weizman A, Leibovici L. Thyroxine-triiodothyronine combination therapy versus thyroxine monotherapy for clinical hypothyroidism: Meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2006; 91(7): 2592-9.
[http://dx.doi.org/10.1210/jc.2006-0448] [PMID: 16670166]
[41]
Joffe RT, Brimacombe M, Levitt AJ, Stagnaro-Green A. Treatment of clinical hypothyroidism with thyroxine and triiodothyronine: A literature review and metaanalysis. Psychosomatics 2007; 48(5): 379-84.
[http://dx.doi.org/10.1176/appi.psy.48.5.379] [PMID: 17878495]
[42]
Chao M, Jiawei X, Xia H, et al. Thyroxine alone or thyroxine plus triiodothyronine replacement therapy for hypothyroidism. Nucl Med Commun 2009; 30(8): 586-93.
[http://dx.doi.org/10.1097/MNM.0b013e32832c79e0] [PMID: 19491714]
[43]
Abrahamsen B, Jørgensen HL, Laulund AS, et al. The excess risk of major osteoporotic fractures in hypothyroidism is driven by cumulative hyperthyroid as opposed to hypothyroid time: An observational register-based time-resolved cohort analysis. J Bone Miner Res 2015; 30(5): 898-905.
[http://dx.doi.org/10.1002/jbmr.2416] [PMID: 25431028]
[44]
Lillevang-Johansen M, Abrahamsen B, Jørgensen HL, Brix TH, Hegedüs L. Duration of hyperthyroidism and lack of sufficient treatment are associated with increased cardiovascular risk. Thyroid 2019; 29(3): 332-40.
[http://dx.doi.org/10.1089/thy.2018.0320] [PMID: 30648498]
[45]
Thvilum M, Brandt F, Almind D, Christensen K, Hegedüs L, Brix TH. Excess mortality in patients diagnosed with hypothyroidism: A nationwide cohort study of singletons and twins. J Clin Endocrinol Metab 2013; 98(3): 1069-75.
[http://dx.doi.org/10.1210/jc.2012-3375] [PMID: 23365121]
[46]
Hegedüs L, Bonnema SJ, Bennedbæk FN. Management of simple nodular goiter: Current status and future perspectives. Endocr Rev 2003; 24(1): 102-32.
[http://dx.doi.org/10.1210/er.2002-0016] [PMID: 12588812]
[47]
Winther KH, Rayman MP, Bonnema SJ, Hegedüs L. Selenium in thyroid disorders — essential knowledge for clinicians. Nat Rev Endocrinol 2020; 16(3): 165-76.
[http://dx.doi.org/10.1038/s41574-019-0311-6] [PMID: 32001830]
[48]
Wichman J, Winther KH, Bonnema SJ, Hegedüs L. Selenium supplementation significantly reduces thyroid autoantibody levels in patients with chronic autoimmune thyroiditis: A systematic review and meta-analysis. Thyroid 2016; 26(12): 1681-92.
[http://dx.doi.org/10.1089/thy.2016.0256] [PMID: 27702392]
[49]
Andersson M, Berg G, Eggertsen R, et al. Adequate iodine nutrition in Sweden: A cross-sectional national study of urinary iodine concentration in school-age children. Eur J Clin Nutr 2009; 63(7): 828-34.
[http://dx.doi.org/10.1038/ejcn.2008.46] [PMID: 18781164]
[50]
Nyström HF, Brantsæter AL, Erlund I, et al. Iodine status in the Nordic countries - past and present. Food Nutr Res 2016; 60(1): 31969.
[http://dx.doi.org/10.3402/fnr.v60.31969] [PMID: 27283870]
[51]
Völzke H, Lüdemann J, Robinson DM, et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13(8): 803-10.
[http://dx.doi.org/10.1089/105072503768499680] [PMID: 14558922]
[52]
Frates MC, Benson CB, Charboneau JW, et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology 2005; 237(3): 794-800.
[http://dx.doi.org/10.1148/radiol.2373050220] [PMID: 16304103]
[53]
Dressler JWE, Leisner B, Reiners C, Schicha H, Dietlein M. Procedure guideline for thyroid scintigraphy (version 3). Nucl Med (Stuttg) 2007; 46(5): 203-5.
[http://dx.doi.org/10.1160/nukmed-0284] [PMID: 17938755]
[54]
Bojunga J, Herrmann E, Meyer G, Weber S, Zeuzem S, Friedrich-Rust M. Real-time elastography for the differentiation of benign and malignant thyroid nodules: A meta-analysis. Thyroid 2010; 20(10): 1145-50.
[http://dx.doi.org/10.1089/thy.2010.0079] [PMID: 20860422]
[55]
Zimmermann MB. Iodine deficiency. Endocr Rev 2009; 30(4): 376-408.
[http://dx.doi.org/10.1210/er.2009-0011] [PMID: 19460960]
[56]
Rendl J, Saller B. Thyroid gland and X-ray contrast medium: Pathophysiology, frequency and prophylaxis of iodine-induced hyperthyroidism. Dtsch Doctor’s Bl 2001; 98(7): A-402.
[57]
Sandrock D, Olbricht T, Emrich D, Benker G, Reinwein D. Long-term follow-up in patients with autonomous thyroid adenoma. Eur J Endocrinol 1993; 128(1): 51-5.
[http://dx.doi.org/10.1530/acta.0.1280051] [PMID: 8447194]
[58]
Grussendorf M, Reiners C, Paschke R, Wegscheider K. Reduction of thyroid nodule volume by levothyroxine and iodine alone and in combination: A randomized, placebo-controlled trial. J Clin Endocrinol Metab 2011; 96(9): 2786-95.
[http://dx.doi.org/10.1210/jc.2011-0356] [PMID: 21715542]
[59]
Wesche MFT, Tiel-v Buul MMC, Lips P, Smits NJ, Wiersinga WM. A randomized trial comparing levothyroxine with radioactive iodine in the treatment of sporadic nontoxic goiter. J Clin Endocrinol Metab 2001; 86(3): 998-1005.
[http://dx.doi.org/10.1210/jcem.86.3.7244] [PMID: 11238476]
[60]
Papini E, Petrucci L, Guglielmi R, et al. Long-term changes in nodular goiter: A 5-year prospective randomized trial of levothyroxine suppressive therapy for benign cold thyroid nodules. J Clin Endocrinol Metab 1998; 83(3): 780-3.
[http://dx.doi.org/10.1210/jcem.83.3.4615] [PMID: 9506726]
[61]
Fast S, Hegedüs L, Grupe P, et al. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy. J Clin Endocrinol Metab 2010; 95(8): 3719-25.
[http://dx.doi.org/10.1210/jc.2010-0634] [PMID: 20519346]
[62]
Vijayvargiya P, Jameie-Oskooei S, Camilleri M, Chedid V, Erwin PJ, Murad MH. Association between delayed gastric emptying and upper gastrointestinal symptoms: A systematic review and meta-analysis. Gut 2019; 68(5): 804-13.
[http://dx.doi.org/10.1136/gutjnl-2018-316405] [PMID: 29860241]
[63]
Pasricha PJ, Colvin R, Yates K, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol 2011; 9(7): 567-576.e4, 4.
[http://dx.doi.org/10.1016/j.cgh.2011.03.003] [PMID: 21397732]
[64]
Barshop K, Staller K, Semler J, Kuo B. Duodenal rather than antral motility contractile parameters correlate with symptom severity in gastroparesis patients. Neurogastroenterol Motil 2015; 27(3): 339-46.
[http://dx.doi.org/10.1111/nmo.12496] [PMID: 25521513]
[65]
Cogliandro RF, Rizzoli G, Bellacosa L, et al. Is gastroparesis a gastric disease? Neurogastroenterol Motil 2019; 31(5): e13562.
[http://dx.doi.org/10.1111/nmo.13562] [PMID: 30773743]
[66]
Sachdeva P, Malhotra N, Pathikonda M, et al. Gastric emptying of solids and liquids for evaluation for gastroparesis. Dig Dis Sci 2011; 56(4): 1138-46.
[http://dx.doi.org/10.1007/s10620-011-1635-9] [PMID: 21365240]
[67]
Maurer AH, Camilleri M, Donohoe K, et al. The SNMMI and EANM practice guideline for small-bowel and colon transit 1.0. J Nucl Med 2013; 54(11): 2004-13.
[http://dx.doi.org/10.2967/jnumed.113.129973] [PMID: 24092937]
[68]
Orthey P, Dadparvar S, Kamat B, Parkman HP, Maurer AH. Using gastric emptying scintigraphy to evaluate antral contractions and duodenal bolus propagation. Am J Physiol Gastrointest Liver Physiol 2020; 318(1): G203-9.
[http://dx.doi.org/10.1152/ajpgi.00274.2019] [PMID: 31682161]
[69]
Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: Establishment of international control values. Am J Gastroenterol 2000; 95(6): 1456-62.
[http://dx.doi.org/10.1111/j.1572-0241.2000.02076.x] [PMID: 10894578]
[70]
Diaz J, Friedman M, Leykekhman A, McCallum R. Determining the optimal projection of the stomach for dynamic antral scintigraphy. J Nucl Med 2018; 59 (Suppl. 1): 1578.
[71]
Camilleri M. Integrated upper gastrointestinal response to food intake. Gastroenterology 2006; 131(2): 640-58.
[http://dx.doi.org/10.1053/j.gastro.2006.03.023] [PMID: 16890616]
[72]
Alipour Z, Khatib F, Tabib SM, et al. Assessment of the prevalence of diabetic gastroparesis and validation of gastric emptying scintigraphy for diagnosis. Mol Imaging Radionucl Ther 2017; 26(1): 17-23.
[http://dx.doi.org/10.4274/mirt.61587] [PMID: 28291006]
[73]
Abrahamsson H. Treatment options for patients with severe gastroparesis. Gut 2007; 56(6): 877-83.
[http://dx.doi.org/10.1136/gut.2005.078121] [PMID: 17519490]
[74]
Olausson EA, Brock C, Drewes AM, et al. Measurement of gastric emptying by radiopaque markers in patients with diabetes: Correlation with scintigraphy and upper gastrointestinal symptoms. Neurogastroenterol Motil 2013; 25(3): e224-32.
[http://dx.doi.org/10.1111/nmo.12075] [PMID: 23316944]
[75]
Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24(7): 1264-9.
[http://dx.doi.org/10.2337/diacare.24.7.1264] [PMID: 11423513]
[76]
Samsom M, Vermeijden JR, Smout AJPM, et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: A prospective study in unselected diabetic patients. Diabetes Care 2003; 26(11): 3116-22.
[http://dx.doi.org/10.2337/diacare.26.11.3116] [PMID: 14578248]
[77]
Koch KL, Hasler WL, Yates KP, et al. Baseline features and differences in 48 week clinical outcomes in patients with gastroparesis and type 1 vs type 2 diabetes. Neurogastroenterol Motil 2016; 28(7): 1001-15.
[http://dx.doi.org/10.1111/nmo.12800] [PMID: 26946489]
[78]
Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005; 129(5): 1756-80.
[http://dx.doi.org/10.1053/j.gastro.2005.09.020] [PMID: 16285971]
[79]
Griffith GH, Owen GM, Kirkman S, Shields R. Measurement of rate of gastric emptying using chromium-51. Lancet 1966; 287(7449): 1244-5.
[http://dx.doi.org/10.1016/S0140-6736(66)90247-9] [PMID: 4161213]
[80]
Javadi H, Bayani H, Mogharrabi M, et al. Relation between clinical features and gastric emptying time in diabetic patients. Nuclear Medicine Review 2015; 18(1): 3-6.
[http://dx.doi.org/10.5603/NMR.2015.0002] [PMID: 25633509]
[81]
Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci 1998; 43(11): 2398-404.
[http://dx.doi.org/10.1023/A:1026665728213] [PMID: 9824125]
[82]
Samsom M, Akkermans LM, Jebbink RJ, van Isselt H, vanBerge-Henegouwen GP, Smout AJ. Gastrointestinal motor mechanisms in hyperglycaemia induced delayed gastric emptying in type I diabetes mellitus. Gut 1997; 40(5): 641-6.
[http://dx.doi.org/10.1136/gut.40.5.641] [PMID: 9203944]
[83]
Anudeep V, Vinod KV, Pandit N, et al. Prevalence and predictors of delayed gastric emptying among Indian patients with long-standing type 2 diabetes mellitus. Indian J Gastroenterol 2016; 35(5): 385-92.
[http://dx.doi.org/10.1007/s12664-016-0694-4] [PMID: 27667549]
[84]
Annese V, Bassotti G, Caruso N, et al. Gastrointestinal motor dysfunction, symptoms, and neuropathy in noninsulin-dependent (type 2) diabetes mellitus. J Clin Gastroenterol 1999; 29(2): 171-7.
[http://dx.doi.org/10.1097/00004836-199909000-00014] [PMID: 10478880]
[85]
Jung HK, Choung RS, Locke GR III, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology 2009; 136(4): 1225-33.
[http://dx.doi.org/10.1053/j.gastro.2008.12.047] [PMID: 19249393]
[86]
Gustafsson RJ, Littorin B, Berntorp K, et al. Esophageal dysmotility is more common than gastroparesis in diabetes mellitus and is associated with retinopathy. Rev Diabet Stud 2011; 8(2): 268-75.
[http://dx.doi.org/10.1900/RDS.2011.8.268] [PMID: 22189550]
[87]
Ertay T, Doğan AS, Ülker Ö, Durak H. In vitro evaluation of tc-99m radiopharmaceuticals for gastric emptying studies. Mol Imaging Radionucl Ther 2014; 23(1): 21-4.
[http://dx.doi.org/10.4274/Mirt.75047] [PMID: 24653931]
[88]
Parkman HP. Scintigraphy for evaluation of patients for GI motility disorders--the referring physician’s perspective. Semin Nucl Med 2012; 42(2): 76-8.
[http://dx.doi.org/10.1053/j.semnuclmed.2011.10.006] [PMID: 22293162]
[89]
Maurer AH. Advancing gastric emptying studies: Standardization and new parameters to assess gastric motility and function. Semin Nucl Med 2012; 42(2): 101-12.
[http://dx.doi.org/10.1053/j.semnuclmed.2011.10.001] [PMID: 22293165]
[90]
Ziessman HA, Chander A, Clarke JO, Ramos A, Wahl RL. The added diagnostic value of liquid gastric emptying compared with solid emptying alone. J Nucl Med 2009; 50(5): 726-31.
[http://dx.doi.org/10.2967/jnumed.108.059790] [PMID: 19372480]
[91]
Knight LC, Kantor S, Doma S, Parkman HP, Maurer AH. Egg labeling methods for gastric emptying scintigraphy are not equivalent in producing a stable solid meal. J Nucl Med 2007; 48(11): 1897-900.
[http://dx.doi.org/10.2967/jnumed.107.044636] [PMID: 17942806]
[92]
Krishnaiah YS, Satyanarayana S, Prasad YV, Rao SN. In vivo evaluation of 99mTc-DTPA and 99mTc-sulphur colloid as tracers in colonic drug delivery systems using gamma scintigraphy in volunteers. J Pharm Pharm Sci 2002; 5(1): 24-8.
[PMID: 12042116]
[93]
Timmons S, Liston R, Moriarty KJ. Functional dyspepsia: Motor abnormalities, sensory dysfunction, and therapeutic options. Am J Gastroenterol 2004; 99(4): 739-49.
[http://dx.doi.org/10.1111/j.1572-0241.2004.04086.x] [PMID: 15089910]
[94]
Shindo T, Futagami S, Hiratsuka T, et al. Comparison of gastric emptying and plasma ghrelin levels in patients with functional dyspepsia and non-erosive reflux disease. Digestion 2009; 79(2): 65-72.
[http://dx.doi.org/10.1159/000205740] [PMID: 19246923]
[95]
Karamanolis G, Caenepeel P, Arts J, Tack J. Association of the predominant symptom with clinical characteristics and pathophysiological mechanisms in functional dyspepsia. Gastroenterology 2006; 130: 296-303.
[96]
Delgado-Aros S, Camilleri M, Cremonini F, Ferber I, Stephens D, Burton DD. Contributions of gastric volumes and gastric emptying to meal size and postmeal symptoms in functional dyspepsia. Gastroenterology 2004; 127(6): 1685-94.
[http://dx.doi.org/10.1053/j.gastro.2004.09.006] [PMID: 15578506]
[97]
Asano H, Tomita T, Nakamura K, et al. Prevalence of gastric motility disorders in patients with functional dyspepsia. J Neurogastroenterol Motil 2017; 23(3): 392-9.
[http://dx.doi.org/10.5056/jnm16173] [PMID: 28423481]
[98]
Ochi M, Tominaga K, Tanaka F, et al. Clinical classification of subgroups according to the Rome III criteria cannot be used to distinguish the associated respective pathophysiology in Japanese patients with functional dyspepsia. Intern Med 2013; 52(12): 1289-93.
[http://dx.doi.org/10.2169/internalmedicine.52.9205] [PMID: 23774536]
[99]
Vanheel H, Carbone F, Valvekens L, et al. Pathophysiological Abnormalities in Functional Dyspepsia Subgroups According to the Rome III Criteria. Am J Gastroenterol 2017; 112(1): 132-40.
[http://dx.doi.org/10.1038/ajg.2016.499] [PMID: 27958284]
[100]
Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121(3): 526-35.
[http://dx.doi.org/10.1053/gast.2001.27180] [PMID: 11522735]

Rights & Permissions Print Cite
Article Metrics
27
3
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy